Recent IMUX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:31:36 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 10:40:33 AM
- Immunic Appoints Jason Tardio as Chief Operating Officer and President • PR Newswire (US) • 07/09/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:07:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/10/2024 08:05:34 PM
- Immunic to Participate in Industry and Scientific Conferences in June • PR Newswire (US) • 05/28/2024 10:30:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/24/2024 08:06:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:20:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 10:45:32 AM
- Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/08/2024 10:30:00 AM
- Immunic to Participate in Investor and Scientific Conferences in May • PR Newswire (US) • 05/06/2024 10:30:00 AM
- Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update • PR Newswire (US) • 05/01/2024 10:30:00 AM
- Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation • PR Newswire (US) • 04/30/2024 10:30:00 AM
- Immunic to Host MS R&D Day and Participate in Investor Conferences in April • PR Newswire (US) • 04/04/2024 10:30:00 AM
- Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States • PR Newswire (US) • 03/20/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:05:28 PM
- Immunic to Participate in Investor and Scientific Conferences in March • PR Newswire (US) • 03/07/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:52:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:51:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:51:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:50:46 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM